Literature DB >> 11096708

Cerebral Edema: Hypertonic Saline Solutions.

.   

Abstract

Our experience, and that of others, suggests that hypertonic saline solution therapy reduces intracranial pressure and lateral displacement of the brain in patients with cerebral edema. This therapy appears most promising in patients who have head trauma or postoperative cerebral edema. Studies comparing hypertonic saline therapy with conventional therapies are limited. Additional randomized studies are needed to determine its safety and optimum duration of benefit and to determine the lesions most likely to be improved. To date, the cost effectiveness of hypertonic saline therapy is unknown. Caution is advised regarding its use until the results of more definitive trials investigating its efficacy and safety are known.

Entities:  

Year:  1999        PMID: 11096708     DOI: 10.1007/s11940-999-0002-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  16 in total

1.  Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients.

Authors:  J D Miller; P Leech
Journal:  J Neurosurg       Date:  1975-03       Impact factor: 5.115

2.  Hypertonic saline lowers raised intracranial pressure in children after head trauma.

Authors:  B Fisher; D Thomas; B Peterson
Journal:  J Neurosurg Anesthesiol       Date:  1992-01       Impact factor: 3.956

Review 3.  Hypertonic saline as a safe and efficacious treatment of intracranial hypertension.

Authors:  M H Zornow
Journal:  J Neurosurg Anesthesiol       Date:  1996-04       Impact factor: 3.956

4.  Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes.

Authors:  J E Cottrell; A Robustelli; K Post; H Turndorf
Journal:  Anesthesiology       Date:  1977-07       Impact factor: 7.892

5.  Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain.

Authors:  A I Qureshi; J I Suarez; A Bhardwaj; M Mirski; M S Schnitzer; D F Hanley; J A Ulatowski
Journal:  Crit Care Med       Date:  1998-03       Impact factor: 7.598

6.  7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures.

Authors:  M Gemma; S Cozzi; C Tommasino; M Mungo; M R Calvi; A Cipriani; M P Garancini
Journal:  J Neurosurg Anesthesiol       Date:  1997-10       Impact factor: 3.956

Review 7.  Malignant cerebral edema and intracranial hypertension.

Authors:  W E Bingaman; J I Frank
Journal:  Neurol Clin       Date:  1995-08       Impact factor: 3.806

8.  Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients.

Authors:  J P Muizelaar; H A Lutz; D P Becker
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

9.  Hypertonic saline fluid therapy following brain stem trauma.

Authors:  M Gemma; S Cozzi; S Piccoli; S Magrin; A De Vitis; M Cenzato
Journal:  J Neurosurg Anesthesiol       Date:  1996-04       Impact factor: 3.956

10.  Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure.

Authors:  H E James; T W Langfitt; V S Kumar; S Y Ghostine
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

View more
  8 in total

1.  Global cerebral edema from hypercapnic respiratory acidosis and response to hyperosmolar therapy.

Authors:  David Roh; Alexander E Merkler; Fawaz Al-Mufti; Nicholas Morris; Sachin Agarwal; Jan Claassen; Soojin Park
Journal:  Neurology       Date:  2016-03-18       Impact factor: 9.910

2.  The effect of reductive ventricular osmotherapy on the osmolarity of artificial cerebrospinal fluid and the water content of cerebral tissue ex vivo.

Authors:  Rick M Odland; S Scott Panter; Gaylan L Rockswold
Journal:  J Neurotrauma       Date:  2011-01       Impact factor: 5.269

3.  Introducing hypertonic saline for cerebral edema: an academic center experience.

Authors:  Lisa L Larive; Denise H Rhoney; Dennis Parker; William M Coplin; J Ricardo Carhuapoma
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 4.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 5.  Osmotherapy in neurocritical care.

Authors:  Anish Bhardwaj
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

6.  Treatment of cerebellar masses.

Authors:  Mahmut Edip Gurol; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

7.  Malignant Cerebral Edema following CT Myelogram Using Isovue-M 300 Intrathecal Nonionic Water-Soluble Contrast: A Case Report.

Authors:  Brian C Kelley; Simon Roh; Philip L Johnson; Paul M Arnold
Journal:  Radiol Res Pract       Date:  2011-01-13

Review 8.  Clinical review: ketones and brain injury.

Authors:  Hayden White; Balasubramanian Venkatesh
Journal:  Crit Care       Date:  2011-04-06       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.